A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts
Koshi Kawakami(Osaka University of Economics), Yoshio Honma(National Cancer Center Hospital East), Miki Tongu, Junji Suzumiy, Miho Akimoto(Teikyo University), Keizo Takenaga(Chiba Cancer Center), Junko Ohkanda(Shinshu University), Takeshi Sassa(Yamagata University), Miho Hattori, Takaya Yamada, Nobuo Kato(Kanazawa Medical University), Yuriko Maruyama, Takatsugu Inoue
Cited by 36
Related Papers
Semi-wet peptide/protein array using supramolecular hydrogel
|Nature Materials|2003|555
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.
|Proceedings of the National Academy of Sciences|1983|255